Home › Researcher directory › Hussein Abou‐Hamdan

Hussein Abou‐Hamdan

Affiliation : Inserm · Regenerative NanoMedicine · Université de Strasbourg

2Publications (affiliation in France)
32Total publications
987Citations
10h-index

Research profile

Hussein Abou‐Hamdan has 2 indexed publications (2020–2022). Their work appears mainly in “European Journal of Medicinal Chemistry” and “Cellular and Molecular Life Sciences”. Their most cited article, “Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases” (2020), has been cited 61 times. Their work is co-authored with at least 6 researchers, including institutions in Algeria, China.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

PI3K/AKT/mTOR signaling in cancer
Synthesis and bioactivity of alkaloids
Bladder and Urothelial Cancer Treatments
Synthesis and biological activity
Bioactive natural compounds

Publications (2)

Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis
2022 · European Journal of Medicinal Chemistry · cited 7 times
Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases
2020 · Cellular and Molecular Life Sciences · cited 61 times

Publication venues

European Journal of Medicinal Chemistry × 1
Cellular and Molecular Life Sciences × 1

Publications per year

20221
20201

Collaborations

Partner institutions : Centre National de la Recherche Scientifique · Tianjin University of Science and Technology · Ecole Nationale Supérieure de Biotechnologie Taoufik Khaznadar · University of Batna 1

Co-authors’ countries : Algeria · China

Co-authors

Bibliographic data from OpenAlex (open database).